John W Hollis Inc Recalls Cyanocobalamin Injection Due to Sterility Concerns
John W Hollis Inc is recalling specific lots of Cyanocobalamin injection because the products lack assurance of sterility. The recall covers 2,650 mL distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, FDA Class II recalls with potential for significant injury or hospitalization (implied by the lack of sterility in injectables) are rated as Severe (4).
Plain-English summary
John W Hollis Inc is recalling 2,650 mL of Cyanocobalamin for intramuscular or subcutaneous use. The recall is due to a lack of assurance of sterility in the compounded aseptically filled injectable products. The affected product is a 30 mL vial containing 1000 mcg of Cyanocobalamin per mL, along with Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric Acid, and/or Sodium Hydroxide.
The recall covers five specific lots: Lot # 940 (Best used by 08/01/14), Lot # 1090 (Best used by 08/29/14), Lot # 1533 (Best used by 05/24/14), Lot # 1838 (Best used by 07/15/14), and Lot # 2755 (Best used by 10/06/14). The products were distributed nationwide.
Consumers and healthcare providers should stop using the affected lots and contact their healthcare provider or the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- CYANOCOBALAMIN FOR INTRAMUSCULAR OR SUBCUTANEOUS USE ONLY, Each mL contains: Cyanocobalamin 1000 mcg, , Also Contains: Benzyl Alcohol, Sodium Chloride, Water, Hydrochloric Acid, and/or Sodium Hydroxide, 30 mL, JOHN HOLLIS Pharmacist Inc, 110 20th Avenue N, Nashville, TN 37203, 6
- Manufacturer
- John W Hollis Inc
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 940
- Best used by 08/01/14
- Lot # 1090
- Best used by 08/29/14
- Lot # 1533
- Best used by 05/24/14
- Lot # 1838
- Best used by 07/15/14
- Lot# 2755
- Best used by 10/06/14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 19 recalled by John W Hollis Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 19 products in this recall →Related recalls
Same manufacturer · John W Hollis Inc
See all →- SevereJohn W Hollis Inc Recalls Liver Derivative Complex Injection for Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Compounded Injectable Drug Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Compounded Injectable Products Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol 1% Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29